<div><div></div><div>Acura Pharmaceuticals amended its secured promissory note with Abuse Deterrent Pharma to record new advances totaling $300,000 funded on Feb 6, Feb 13, and Mar 9, 2026. Including prior loans and $2.32 million under the Nov 10, 2022 note, principal stands at $9.89 million with about $1.04 million of accrued interest as of Feb 28, 2026, bearing interest at 5.25% (7.5% on overdue amounts). The note currently matures on Jun 30, 2026. Proceeds will support day-to-day operations while the company seeks additional financing.Agreement details:<ul><li>Agreement type: Secured promissory note; amended loan schedule with additional advances</li><li>Counterparty: Abuse Deterrent Pharma</li><li>Signed / Effective: Mar 09 2026 / same</li><li>Duration / Termination: Through Jun 30 2026</li><li>Reason: Support day-to-day operations and liquidity</li></ul>Original SEC Filing: ACURA PHARMACEUTICALS, INC [ ACUR ] - 8-K - Mar. 10, 2026<section>Disclaimer<div>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</div></section></div></div>

ACRS

Acura Pharmaceuticals has amended its secured promissory note with Abuse Deterrent Pharma, receiving $300,000 in new advances. The total principal now stands at $9.89 million, with accrued interest of approximately $1.04 million at a rate of 5.25%. The note matures on June 30, 2026, and the funds will be used to support daily operations while seeking additional financing.

TradingView

Health Care Select Sector SPDR

iShares Global Healthcare

Aclaris Therap

ALPS Medical Breakthrough

Vertex Pharma

Acurx Pharmaceuticals

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

SPDR S&P Biotech

Ark Genomic Revolution ETF

Invesco Nasdaq Biotechnology ETF

Invesco Biotechnology & Genome ETF

VG Health

VanEck Biotech ETF

iShares US Pharma

Acura Pharmaceuticals Receives $300,000 From AD Pharma; Secured Note Balance Reaches $9.89 Million at 5.25%